| Net Cash Provided by (Used in) Operating Activities |
$337,818,000 |
USD |
-15% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$644,209,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$247,870,000 |
USD |
-3618% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$58,261,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$457,521,000 |
USD |
-14% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$205,637,000 |
USD |
23% |
Q3 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$115,998,000 |
USD |
-40% |
Q4 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$628,055,000 |
USD |
-21% |
Q4 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$266,459,000 |
USD |
7.7% |
Q3 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$12,170,231,000 |
USD |
6.5% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$61,124,000 |
USD |
1.5% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$75,886,000 |
USD |
6.4% |
Q3 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0419 |
pure |
8.8% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$11,361,000 |
USD |
66% |
Q4 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$25,054,000 |
USD |
4.3% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$44,889,000 |
USD |
3.4% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$114,433,000 |
USD |
29% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$96,549,000 |
USD |
48% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$30,063,000 |
USD |
4.8% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$170,836,000 |
USD |
16% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$852,610,000 |
USD |
6% |
Q3 2025 |
FY 2025 |
| Interest Expense |
$155,782,000 |
USD |
53% |
Q4 2025 |
Q1 2026 |